Hematologic Cancer

These guidelines and other documents provide advice for different types of hematologic cancer: non-Hodgkin lymphoma, leukemia, multiple myeloma, Hodgkin lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis.

CAR T-cell Therapy Enrolment

Displaying Guidelines

15 articles

Adult Acute Leukemia Services Plan for the Greater Toronto Area - Recommendations Report

Document Status: Current
ID: GL-C50-02

Jan 2012

Alemtuzumab in Chronic Lymphocytic Leukemia

Document Status: Education and Information
ID: 6-16 Version 2
Version: 2

Feb 2014

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

Management of Early-Stage Hodgkin Lymphoma

Document Status: Current
ID: GL 6-20
Version: 2

May 2023

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Document Status: Education and Information
ID: 6-6 Version 2
Version: 2

Jan 2012

Organizational Requirements for Acute Leukemia Service Providers in Ontario: Recommendations Report 2024

Document Status: Current
Version: 2

Updated

Dec 2024

Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline

Document Status: Archived
ID: 6-8
Version: 3

Mar 2015

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Document Status: Current
Version: 1

Jun 2018

Systemic Therapy in Acute Lymphoblastic Leukemia

Document Status: Archived
ID: 12-16

Jun 2016

Systemic Treatment of Acute Myeloid Leukemia (AML)

Document Status: In-Review
ID: 12-9

Jan 2016

Thalidomide in Multiple Myeloma

Document Status: Archived
ID: 6-21

Jan 2010

The Role of Bisphosphonates in the Management of Skeletal Complications for Patients with Multiple Myeloma

Document Status: Archived
ID: 6-4

Oct 2012